Atherosclerosis. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: Intervention group: atherosclerotic patient that intervention with ginger with doses of 1600 mg ginger per day ( 800 mg before lunch and 800 mg before dinner). The intervention will c
Treatment - Drugs
Placebo
Intervention group: atherosclerotic patient that intervention with ginger with doses of 1600 mg ginger per day ( 800 mg before lunch and 800 mg before dinner). The intervention will continue for 2 mo
Control group: receive Placebo that contain wheat flour. To create the aroma in the placebo capsules, the capsules is placed near the ginger powder for 2 weeks and then packed in cans similar. Patient
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University Of Medical Sceiences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included: all patients (men and women) with atherosclerosis eligible for medical treatment by Cardiologist; and age 40 to 70 years. exclusion criteria including: those patient consuming below 80% of supplement; and change drugs in during intervention.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lysophosphatidic acid. Timepoint: after two month intervention. Method of measurement: Elisa methods.;Lipids profile. Timepoint: after two month intervention. Method of measurement: chemical methods.;Total antioxidant capacity. Timepoint: after two month intervention. Method of measurement: chemical methods.;High-sensitivity C-reactive protein. Timepoint: after two month intervention. Method of measurement: Elisa methods. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Hoseein Babaahmadi
Ahvaz Jundishapur University Of Medical Sceiences
Outcome results
None listed